CN102258664A - Chinese medicinal composition for treating osteoporosis - Google Patents
Chinese medicinal composition for treating osteoporosis Download PDFInfo
- Publication number
- CN102258664A CN102258664A CN2010101926409A CN201010192640A CN102258664A CN 102258664 A CN102258664 A CN 102258664A CN 2010101926409 A CN2010101926409 A CN 2010101926409A CN 201010192640 A CN201010192640 A CN 201010192640A CN 102258664 A CN102258664 A CN 102258664A
- Authority
- CN
- China
- Prior art keywords
- medicinal composition
- chinese medicinal
- chinese
- osteoporosis
- treating osteoporosis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a Chinese medicinal composition for treating osteoporosis. The Chinese medicinal composition is prepared from the following Chinese medicines: tortoise plastron, medlar, eucommia bark, ginseng, south dodder seed, prepared rehmannia root, cinnamomvine, Chinese date, largehead atractylodes rhizome, tuckahoe and glossy privet fruit. The Chinese medicinal composition is easy to prepare, low in cost, wide in medicinal sources, convenient to use, good in curative effect and high in cure rate and does not have any side or side effect.
Description
Technical field
The present invention relates to the osteoporotic Chinese medicine composition of a kind of treatment, belong to the field of Chinese medicines.
Background technology
Osteoporosis is postmenopausal women and old people's a kind of commonly encountered diseases and a frequently-occurring disease, become human modal disease at present, along with the continuous growth of population and the arrival of senescence society, osteoporosis and caused fracture thereof have become a serious social concern, therefore many people suffer sensual misery for a long time, even wounded or disabled and early death, and the medical expense of great number brings huge stress and heavy financial burden also for patient family and society.Therefore, prevention and treatment of osteoporosis has become the focus that the whole society pays close attention to.Reports such as Manners, the U.S. causes that by osteoporosis fracture patients is about 1,500,000 examples every year, and sufferers of osteoporosis face estimates at 1,000 ten thousand examples, and medical expense is up to 150～30,000,000,000 dollars.Japan's nineteen ninety statistics has 1/3 people to suffer from osteoporosis among national over-65s 1,500 ten thousand old peoples approximately.Reached 1.3 hundred million to the old people of China more than 60 years old in 2000, suffer from osteoporosis person and be about 6000～8,000 ten thousand, and according to the investigation in Shanghai City, the present population in Shanghai City is about 1,400 ten thousand, senile osteoporosis prevalence male is 60.72%, and the women is 90.47%.The sickness rate of present clinical osteoporosis is very high, but lacks safe and effective medicine, and the medicine of actively developing the treatment osteoporosis is very necessary.
Summary of the invention
The objective of the invention is at using the existing weak point of medicine in the treatment osteoporosis at present, and a kind of Chinese medicine for oral administration of treatment gastritis cheap, evident in efficacy is provided.
For achieving the above object, the osteoporotic Chinese medicine for oral administration of a kind of treatment is to be made by the raw material of following weight parts: Carapax et Plastrum Testudinis 10-15g, Fructus Lycii 10-15g, Cortex Eucommiae 15-20g, Radix Ginseng 10-15g, Semen Cuscutae 10-15g, Radix Rehmanniae Preparata 10-15g, Rhizoma Dioscoreae 10-15g, Fructus Jujubae 10-15g, Rhizoma Atractylodis Macrocephalae 15-20g, Poria 10-15g, Fructus Ligustri Lucidi 10-15g.
Chinese medicine of the present invention is decocted in water for oral dose, 1 day 1 dose, decoct twice altogether, fried about 200ml, sooner or later sub-service.Effective percentage is more than 90%.
The specific embodiment
The invention will be further described below in conjunction with embodiment.
Embodiment 1: the osteoporotic Chinese medicine composition of a kind of treatment is to be made by the raw material of following weight parts: Carapax et Plastrum Testudinis 10g, Fructus Lycii 10g, Cortex Eucommiae 15g, Radix Ginseng 10g, Semen Cuscutae 10g, Radix Rehmanniae Preparata 10g, Rhizoma Dioscoreae 10g, Fructus Jujubae 10g, Rhizoma Atractylodis Macrocephalae 15g, Poria 10g, Fructus Ligustri Lucidi 10g.Be decocted in water for oral dose, 1 day 1 dose, decoct twice altogether, fried about 200ml, sooner or later sub-service.Effective percentage is more than 90%.
Claims (1)
1. the osteoporotic Chinese medicine composition of treatment is characterized in that it is to be made by the raw material of following weight parts: Carapax et Plastrum Testudinis 10-15g, Fructus Lycii 10-15g, Cortex Eucommiae 15-20g, Radix Ginseng 10-15g, Semen Cuscutae 10-15g, Radix Rehmanniae Preparata 10-15g, Rhizoma Dioscoreae 10-15g, Fructus Jujubae 10-15g, Rhizoma Atractylodis Macrocephalae 15-20g, Poria 10-15g, Fructus Ligustri Lucidi 10-15g.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010101926409A CN102258664A (en) | 2010-05-28 | 2010-05-28 | Chinese medicinal composition for treating osteoporosis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010101926409A CN102258664A (en) | 2010-05-28 | 2010-05-28 | Chinese medicinal composition for treating osteoporosis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102258664A true CN102258664A (en) | 2011-11-30 |
Family
ID=45005630
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2010101926409A Pending CN102258664A (en) | 2010-05-28 | 2010-05-28 | Chinese medicinal composition for treating osteoporosis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102258664A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107006681A (en) * | 2016-01-28 | 2017-08-04 | 柳泓善 | Animal feed composition containing Chinese medicinal material extract |
-
2010
- 2010-05-28 CN CN2010101926409A patent/CN102258664A/en active Pending
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107006681A (en) * | 2016-01-28 | 2017-08-04 | 柳泓善 | Animal feed composition containing Chinese medicinal material extract |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101653529A (en) | Medicine for treating allergic rhinitis | |
| CN104758825A (en) | Traditional Chinese medicine composition for treating amenorrhea | |
| CN102488743B (en) | Chinese traditional medicine composition, preparation method thereof and Chinese traditional medicine preparation | |
| CN104001035A (en) | Trichosanthis Radix and Radix Puerariae-containing traditional Chinese medicinal preparation for treating type 2 diabetes mellitus | |
| CN104800382A (en) | Traditional Chinese medicine composition for treating colds, as well as preparation method and application thereof | |
| CN102988887A (en) | Chinese medicament for treating ovarian cyst | |
| CN102961546A (en) | Traditional Chinese medicine prescription for treating biliary tract ascariasis | |
| CN103417877A (en) | Cancer treatment and prevention by utilization of herbal medicine | |
| CN102961647A (en) | Traditional Chinese medicine for treating osteoporosis | |
| CN105233017A (en) | Traditional Chinese medicine decoction for treatment of lung-deficiency cough | |
| CN104547623A (en) | Traditional Chinese medicine composition for reducing fats | |
| CN102423426B (en) | Traditional Chinese medicine composition for treating anaphylactoid purpura | |
| CN101647869A (en) | Traditional Chinese medicine for treating habitual abortion | |
| CN102258664A (en) | Chinese medicinal composition for treating osteoporosis | |
| CN102764337A (en) | Traditional Chinese medicine composition for curing hepatitis B | |
| CN103550470B (en) | Healthy traditional Chinese medicine for children | |
| CN103251893B (en) | Traditional Chinese medicine composition for treating male sterility | |
| CN106334152A (en) | Traditional Chinese medicine formula for treating acute hepatitis | |
| CN106138637B (en) | Traditional Chinese medicine composition for promoting blood circulation, removing blood stasis, resisting rheumatism and relieving pain and preparation method thereof | |
| CN103055118A (en) | Traditional Chinese medicine for treating asthma | |
| CN103990083A (en) | Traditional Chinese medicine composition for treating postpartum lochiorrhea | |
| CN102370863B (en) | Traditional Chinese medicine for treating bronchial asthma | |
| CN106492163A (en) | A kind of Chinese medicine preparation for treating the vomiting of pregnancy | |
| CN102078428A (en) | Traditional Chinese medicine composition for treating osteoporosis | |
| CN104258107A (en) | Traditional Chinese medicine for treating postartum convulsion |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20111130 |